*In a six-month clinical trial of 139 men with low testosterone, 88% of patients had normal testosterone levels at Day 90 (worst-case scenario calculation, Investigator Site 104). Based on patients who completed the study (n=127), 96% of patients achieved normal testosterone levels at Day 90.
Become a Better Version of You
Clinically Restore Testosterone Levels
At Day 90 in a six-month clinical study of 139 men with low testosterone, patients experienced:
*Sex Hormone Binding Globulin (SHBG) binds to testosterone and decreases free testosterone levels. The less SHBG you have, the higher your free testosterone levels will be.3
Patient and Provider Preference for Oral Testosterone4
*2018 quantitative study of 78 Primary Care Physicians, Endocrinologists and Urologists
†2018 quantitative study of 83 hypogonadal patients; TRT users (n=49), Non-TRT users (n=34)
KYZATREX Patient Testimonials
“I have recently taken my health into my own hands after my labs reflected low testosterone. I have been on KYZATREX for more than 4 months now, and my testosterone levels are back to normal. My life has changed for the better. I really do attribute this jumpstart in health to KYZATREX.”
Bryan N, 56
Real Patient Taking KYZATREX
“For years, I used testosterone injections but wanted to switch to an oral TRT. My doctor recommended KYZATREX due to its tolerability and side effect profile and I’ve now been on KYZATREX for 8 months. My testosterone levels are about 700 ng/dL and I feel just as good, if not better, on KYZATREX than I did on injections.”
Brian R, 47
Real Patient Taking KYZATREX
“When I first discovered I had Low T, I went with pellet therapy. While pellets seemed fine at first, they eventually became too much of a hassle – the painful implant process, scar tissue buildup and activity restrictions just weren’t for me, especially when the effects started wearing off before the next dose. As soon as I heard there was an oral option, that’s when I switched to KYZATREX. I love the convenience of the capsules, and my testosterone levels are in the normal range! It’s made a real difference in how I feel.”
David W, 41
Real Patient Taking KYZATREX
“KYZATREX is the medication that has worked for me, providing relief for my Klinefelter’s Syndrome.”
William K, 37
Real Patient Taking KYZATREX
Take the First Step Today
Get KYZATREX
Start taking control of your testosterone levels. Discover the difference KYZATREX can make in managing Low T.
Easy to Take
Daily Oral Dosing
Testosterone-boosting benefits in two capsules taken twice daily
KYZATREX is not a gel, injection, pellet, or patch. Just take two KYZATREX oral capsules twice daily with food to help restore testosterone to normal levels and keep it there.
The best part? You don’t need to change your diet or eating habits to accommodate this treatment. It’s designed to fit seamlessly into your daily routine.
Natural Production Rhythm
Works with Your Body to Bring Testosterone Back into Balance
With a twice-daily dosing schedule, KYZATREX:
- Raises testosterone levels each time you take it (2 times per day). After each dose, your testosterone levels slowly decline before your next dose.
- Focuses on maintaining your testosterone within a range that is considered medically normal.
- Won’t cause unnatural highs or extreme lows in your testosterone levels.
- Can raise your testosterone levels while maintaining your own testosterone production.
Flexible Dosing
Different Doses for Different Dudes
Your KYZATREX dose is tailored to your unique needs, with adjustable dosages to find the right balance for you.
Demonstrated Safety
Most Common Side Effects
In a clinical study of 155 patients, the most common adverse event was high blood
pressure (observed in 2.6% of patients taking KYZATREX).
Your healthcare provider will monitor your blood pressure while you are being treated
with KYZATREX. If your blood pressure increases, you may need to start medication to
control your blood pressure.
For additional risk information, please see the Important Safety Information below.
References:
-
- Bernstein JS. Dhingra OP. A phase III, single-arm, 6-month trial of a wide-dose range oral testosterone undecanoate product. Ther Adv Urol. 2024;16:1-17. doi: 10.177/17562872241241864
- Data on file. Raleigh, NC: Marius Pharmaceuticals, 2020.
- Krakowsky Y, Grober E. Testosterone deficiency – Establishing a Biochemical Diagnosis. EJIFCC. 2015 Mar; 26(2): 105–113.PMID: 27683486; PMCID: PMC4975356.
- Data on file. Raleigh, NC: Marius Pharmaceuticals, 2018.
